Genetic markers associated to dyslipidemia in HIV-infected individuals on HAART

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Lazzaretti, Rosmeri K ^a   Gasparotto, Aline S ^b   Sassi, Marina G De M ^b   Polanczyk, Carísi A ^a   Kuhmmer, Regina ^a   Silveira, Jussara M ^c   Basso, Rossana P ^c   Pinheiro, Cezar A T ^d   Silveira, Mariângela F ^d   Sprinz, Eduardo ^a   Mattevi, Vanessa S ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c Hospital Universitário   (Brazil)

^d FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEINASE INHIBITOR; TRIACYLGLYCEROL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; BRAZIL; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETIC PREDISPOSITION; GENETICS; MULTICENTER STUDY; RISK FACTOR; STATISTICS; UTILIZATION REVIEW;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; COMORBIDITY; DYSLIPIDEMIAS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; VIRAL LOAD;

EID: 84885591944     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/608415     Document Type: Article

References (39)

1. Taiwo B. O., Li X., Palella F., Jacobson L. P., Margolick J. B., Detels R., Rinaldo C. R., Phair J. P., Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART. HIV Medicine 2009 10 10 657 660 2-s2.0-70449356789 10.1111/j.1468-1293.2009.00739.x
2. Marins J. R. P., Jamal L. F., Chen S. Y., Barros M. B., Hudes E. S., Barbosa A. A., Chequer P., Teixeira P. R., Hearst N., Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS 2003 17 11 1675 1682 2-s2.0-0043130150 10.1097/00002030-200307250-00012 (Pubitemid 36951688)
3. Dubé M. P., Stein J. H., Aberg J. A., Fichtenbaum C. J., Gerber J. G., Tashima K. T., Henry W. K., Currier J. S., Sprecher D., Glesby M. J., Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clinical Infectious Diseases 2003 37 5 613 627 2-s2.0-0042832397 10.1086/378131 (Pubitemid 37100800)
4. Fox J., Boffito M., Winston A., The clinical implications of antiretroviral pharmacogenomics. Pharmacogenomics 2006 7 4 587 596 2-s2.0-33745142883 10.2217/14622416.7.4.587 (Pubitemid 43891415)
5. Chang M.-H., Yesupriya A., Ned R. M., Mueller P. W., Dowling N. F., Genetic variants associated with fasting blood lipids in the U.S. population: third National Health and Nutrition Examination Survey. BMC Medical Genetics 2010 11 1, article 62 2-s2.0-77950948152 10.1186/1471-2350-11-62
6. de Andrade F. M., Maluf S. W., Schuch J. B., Voigt F., Barros A. C., Lucatelli J. F., Hutz M. H., The influence of the S19W SNP of the APOA5 gene on triglyceride levels in southern Brazil: interactions with the APOE gene, sex and menopause status. Nutrition, Metabolism and Cardiovascular Diseases 2011 21 8 584 590 2-s2.0-79961126019 10.1016/j.numecd.2009.12.013
7. Fiegenbaum M., Silveira F. R., van der Sand C. R., van der Sand L. C., Ferreira M. E. W., Pires R. C., Hutz M. H., Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes. Pharmacogenomics Journal 2005 5 6 359 364 2-s2.0-33644677542 10.1038/sj.tpj.6500334
8. Fiegenbaum M., de Andrade F. M., Hutz M. H., Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes. Clinica Chimica Acta 2007 380 1-2 175 181 2-s2.0-33947642520 10.1016/j.cca.2007.02.007 (Pubitemid 46498054)
9. Rios D. L. S., Vargas A. F., Torres M. R., Zago A. J., Callegari-Jacques S. M., Hutz M. H., Interaction between SREBP-1a and APOB polymorphisms influences total and low-density lipoprotein cholesterol levels in patients with coronary artery disease. Clinical Genetics 2003 63 5 380 385 2-s2.0-0042632779 10.1034/j.1399-0004.2003.00057.x (Pubitemid 36944081)
10. Arnedo M., Taffé P., Sahli R., Furrer H., Hirschel B., Elzi L., Weber R., Vernazza P., Bernasconi E., Darioli R., Bergmann S., Beckmann J. S., Telenti A., Tarr P. E., Bachmann S., Battegay M., Bernasconi E., Bucher H., Bürgisser P., Cattacin S., Cavassini M., Egger M., Erb P., Fierz W., Fischer M., Flepp M., Fontana A., Francioli P., Furrer H., Gorgievski M., Günthard H., Hirschel B., Kaiser L., Kind C., Klimkait T., Ledergerber B., Lauper U., Opravil M., Paccaud F., Pantaleo G., Perrin L., Piffaretti J.-C., Rickenbach M., Rudin C., Schüpbach J., Speck R., Tarr P., Telenti A., Trkola A., Vernazza P., Weber R., Yerly S., Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy. Pharmacogenetics and Genomics 2007 17 9 755 764 2-s2.0-34547917168 10.1097/FPC.0b013e32814db8b7 (Pubitemid 47263070)
11. Rotger M., Bayard C., Taffé P., Martinez R., Cavassini M., Bernasconi E., Battegay M., Hirschel B., Furrer H., Witteck A., Weber R., Ledergerber B., Telenti A., Tarr P. E., Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study. Circulation 2009 2 6 621 628 2-s2.0-77449143922 10.1161/CIRCGENETICS.109.874412
12. Kathiresan S., Willer C. J., Peloso G. M., Demissie S., Musunuru K., Schadt E. E., Kaplan L., Bennett D., Li Y., Tanaka T., Voight B. F., Bonnycastle L. L., Jackson A. U., Crawford G., Surti A., Guiducci C., Burtt N. P., Parish S., Clarke R., Zelenika D., Kubalanza K. A., Morken M. A., Scott L. J., Stringham H. M., Galan P., Swift A. J., Kuusisto J., Bergman R. N., Sundvall J., Laakso M., Ferrucci L., Scheet P., Sanna S., Uda M., Yang Q., Lunetta K. L., Dupuis J., De Bakker P. I. W., O'Donnell C. J., Chambers J. C., Kooner J. S., Hercberg S., Meneton P., Lakatta E. G., Scuteri A., Schlessinger D., Tuomilehto J., Collins F. S., Groop L., Altshuler D., Collins R., Lathrop G. M., Melander O., Salomaa V., Peltonen L., Orho-Melander M., Ordovas J. M., Boehnke M., Abecasis G. R., Mohlke K. L., Cupples L. A., Common variants at 30 loci contribute to polygenic dyslipidemia. Nature Genetics 2009 41 1 56 65 2-s2.0-58149163149 10.1038/ng.291
13. Sandhu M. S., Waterworth D. M., Debenham S. L., Wheeler E., Papadakis K., Zhao J. H., Song K., Yuan X., Johnson T., Ashford S., Inouye M., Luben R., Sims M., Hadley D., McArdle W., Barter P., Kesäniemi Y. A., Mahley R. W., McPherson R., Grundy S. M., Bingham S. A., Khaw K.-T., Loos R. J., Waeber G., Barroso I., Strachan D. P., Deloukas P., Vollenweider P., Wareham N. J., Mooser V., LDL-cholesterol concentrations: a genome-wide association study. The Lancet 2008 371 9611 483 491 2-s2.0-38849166666 10.1016/S0140-6736(08)60208-1 (Pubitemid 351199866)
14. Wallace C., Newhouse S. J., Braund P., Zhang F., Tobin M., Falchi M., Ahmadi K., Dobson R. J., Marçano A. C. B., Hajat C., Burton P., Deloukas P., Brown M., Connell J. M., Dominiczak A., Lathrop G. M., Webster J., Farrall M., Spector T., Samani N. J., Caulfield M. J., Munroe P. B., Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. American Journal of Human Genetics 2008 82 1 139 149 2-s2.0-38749149611 10.1016/j.ajhg.2007.11.001 (Pubitemid 351735954)
15. Schneider E., Whitmore S., Glynn K. M., Dominguez K., Mitsch A., McKenna M. T., Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. Morbidity and Mortality Weekly Report 2008 57 10 1 12 2-s2.0-58149197855
16. Zembrzuski V. M., Callegari-Jacques S. M., Hutz M. H., Application of an African ancestry index as a genomic control approach in a Brazilian population. Annals of Human Genetics 2006 70 6 822 828 2-s2.0-33749569805 10.1111/j.1469-1809.2006.00270.x (Pubitemid 44530646)
17. Santos N. P. C., Ribeiro-Rodrigues E. M., Ribeiro-dos-Santos Â. K. C., Pereira R., Gusmão L., Amorim A., Guerreiro J. F., Zago M. A., Matte C., Hutz M. H., Dos Santos S. E. B., Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Human Mutation 2010 31 2 184 190 2-s2.0-75149156628 10.1002/humu.21159
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association 2001 285 19 2486 2497 2-s2.0-0035897696
19. Lahiri D. K., Nurnberger J. L. Jr., A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research 1991 19 19 5444 2-s2.0-0026080111
20. Pajukanta P. E., Valsta L. M., Aro A., Pietinen P., Heliö T., Tikkanen M. J., The effects of the apolipoprotein B signal peptide (ins/del) and XbaI polymorphisms on plasma lipid responses to dietary change. Atherosclerosis 1996 122 1 1 10 2-s2.0-0029928483 10.1016/0021-9150(95)05725-0 (Pubitemid 26135188)
21. Pan J.-P., Chiang A.-N., Tai J. J., Wang S.-P., Chang M.-S., Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease. Clinical Chemistry 1995 41 3 424 429 2-s2.0-0028912829
22. Tregouet D. A., Garelle V., A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007 23 8 1038 1039 2-s2.0-34249662218 10.1093/bioinformatics/btm058 (Pubitemid 47050595)
23. Feeney E. R., Mallon P. W. G., HIV and HAART-associated dyslipidemia. The Open Cardiovascular Medicine Journal 2011 5 49 63 2-s2.0-82855179424 10.2174/1874192401105010049
24. Tarr P. E., Taffe P., Bleiber G., Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. Journal of Infectious Diseases 2005 191 1419 1426 (Pubitemid 40563352)
25. Ordovas J. M., Lopez-Miranda J., Perez-Jimenez F., Rodriguez C., Park J.-S., Cole T., Schaefer E. J., Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy. Atherosclerosis 1995 113 2 157 166 2-s2.0-0028901424 10.1016/0021-9150(94)05439- P
26. Pedro-Botet J., Schaefer E. J., Bakker-Arkema R. G., Black D. M., Stein E. M., Corella D., Ordovas J. M., Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. Atherosclerosis 2001 158 1 183 193 2-s2.0-0034909515 10.1016/S0021-9150(01)00410-5 (Pubitemid 32735483)
27. Mahley R. W., Rall S. C. Jr., Apolipoprotein E: far more than a lipid transport protein. Annual Review of Genomics and Human Genetics 2000 1 2000 507 537 2-s2.0-0034575124
28. Bennet A. M., di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., Keavney B., Collins R., Wiman B., de Faire U., Danesh J., Association of apolipoprotein e genotypes with lipid levels and coronary risk. Journal of the American Medical Association 2007 298 11 1300 1311 2-s2.0-34548736492 10.1001/jama.298.11.1300 (Pubitemid 47443344)
29. Fauvel J., Bonnet E., Ruidavets J.-B., Ferrières J., Toffoletti A., Massip P., Chap H., Perret B., An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients. AIDS 2001 15 18 2397 2406 2-s2.0-0035824763 10.1097/00002030- 200112070-00007 (Pubitemid 34014608)
30. Marzocchetti A., Schwarz J., di Giambenedetto S., Colafigli M., Bracciale L., Fabbiani M., Fantoni M., Trecarichi E., Cauda R., De Luca A., The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy. AIDS Research and Human Retroviruses 2011 27 12 1299 1309 2-s2.0-82455210401 10.1089/aid.2010.0172
31. Seda O., Sedova L., New Apolipoprotein A-V: comparative genomics meets metabolism. Physiological Research 2003 52 141 146 (Pubitemid 36427816)
32. Tai E. S., Ordovas J. M., Clinical significance of apolipoprotein A5. Current Opinion in Lipidology 2008 19 4 349 354 2-s2.0-53149141807 10.1097/MOL.0b013e328304b681
33. Lai C.-Q., Tai E.-S., Tan C. E., Cutter J., Chew S. K., Zhu Y.-P., Adiconis X., Ordovas J. M., The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. Journal of Lipid Research 2003 44 12 2365 2373 2-s2.0-0345832332 10.1194/jlr.M300251-JLR200 (Pubitemid 38082495)
34. Guardiola M., Ferré R., Salazar J., Alonso-Villaverde C., Coll B., Parra S., Masana L., Ribalta J., Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T→C gene variation. Clinical Chemistry 2006 52 10 1914 1919 2-s2.0-33749132365 10.1373/clinchem.2006.069583 (Pubitemid 44470699)
35. Kay A., März W., Hoffmann M. M., Zhang Q., Masana L. I., Cavanna J., Baroni M. G., Shine B., Galton D. J., Coronary artery disease and dyslipidemia within Europe: genetic variants in lipid transport gene loci in German subjects with premature coronary artery disease. Atherosclerosis Supplements 2002 3 1 27 33 2-s2.0-0036583680 10.1016/S1567-5688(01)00003-4 (Pubitemid 38234475)
36. Turner P. R., Talmud P. J., Visvikis S., Ehnholm C., Tiret L., DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: european Atherosclerosis Research Study. Atherosclerosis 1995 116 2 221 234 2-s2.0-0029114443 10.1016/0021-9150(94)05550-3
37. Benn M., Nordestgaard B. G., Jensen J. S., Grande P., Sillesen H., Tybjærg-Hansen A., Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population. Journal of Clinical Endocrinology and Metabolism 2005 90 10 5797 5803 2-s2.0-26244437450 10.1210/jc.2005-0974 (Pubitemid 41415494)
38. Xu C.-F., Tikkanen M. J., Huttunen J. K., Pietinen P., Butler R., Humphries S., Talmud P., Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. Journal of Lipid Research 1990 31 7 1255 1261 2-s2.0-0025338393 (Pubitemid 20224723)
39. Ye P., Chen B., Wang S., Association of polymorphisms of the apolipoprotein B gene with coronary heart disease in Han Chinese. Atherosclerosis 1995 117 1 43 50 2-s2.0-0029154396 10.1016/0021-9150(95)05556-C